Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study to Assess the Long-Term Safety of Tacrolimus Cream in the Treatment of Psoriasis

ClinicalTrials.gov ID: NCT00293917

Public ClinicalTrials.gov record NCT00293917. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 7:21 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Long-Term, Open Label Study to Evaluate the Safety of Twice Daily Tacrolimus Cream-B 0.1% in the Treatment of Psoriasis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A study to assess the long-term safety of tacrolimus cream in the treatment of psoriasis

Study identification

NCT ID
NCT00293917
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Astellas Pharma Inc
Industry
Enrollment
658 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2006 (Type not available)
Primary completion
Aug 2007 (Actual)
Completion
Aug 2007 (Actual)
Last update posted
Feb 13, 2008

2006 – 2007

United States locations

U.S. sites
31
U.S. states
21
U.S. cities
29
Facility City State ZIP Site status
Not listed Birmingham Alabama 30322 —
Not listed Fresno California 93710 —
Not listed Santa Monica California 90404 —
Not listed Vista California 92083 —
Not listed Jacksonville Florida 32204 —
Not listed Miami Florida — —
Not listed Atlanta Georgia 30322 —
Not listed Newnan Georgia 30263 —
Not listed Boise Idaho 83704 —
Not listed Chicago Illinois 60614 —
Not listed Chicago Illinois — —
Not listed Louisville Kentucky 40202 —
Not listed New Orleans Louisiana 70112 —
Not listed Boston Massachusetts 02118 —
Not listed Detroit Michigan 48202 —
Not listed Minneapolis Minnesota 55455 —
Not listed Lincoln Nebraska 68502 —
Not listed Reno Nevada 89511 —
Not listed Lebanon New Hampshire 03756 —
Not listed East Windsor New Jersey 08520 —
Not listed East Setauket New York 11733 —
Not listed New York New York 10016 —
Not listed New York New York 10025 —
Not listed Hershey Pennsylvania 17033 —
Not listed Simpsonville South Carolina 29681 —
Not listed Goodlettsville Tennessee 37072 —
Not listed Arlington Texas 76011 —
Not listed Houston Texas 77056 —
Not listed Bellingham Washington 98225 —
Not listed Kenatchee Washington 98801 —
Not listed Spokane Washington 99202 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00293917, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 13, 2008 · Synced Nov 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00293917 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →